Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • Global United States
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Company
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Science
      < Back
    • Science
    • Areas of focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patients
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
  1. Home
  2. Who We Are
  3. Leadership
  4. leadership

Mari Scheiffele

Post navigation

Previous
Next
Mari Scheiffele

Mari Scheiffele

  • Executive Vice President,
  • International
  • Follow in LinkedIn

Mari Scheiffele joined Ipsen in November 2021 as EVP and President, International.

Mari brings 20 years of healthcare leadership experience, from across the pharmaceutical industry, having worked in the US, Europe and in Japan. She joined Ipsen from Novartis where she had held both global strategy and country operational roles in Japan and in the UK. Prior to joining Ipsen, Mari was the General Manager, Novartis Oncology UK & Ireland where with a focus on patient-centricity, evidence-based medicine, and partnership, she drove a successful business transformation.

In addition to her focus in oncology, Mari has worked in other specialty care environments such as ophthalmology, neuroscience, and immunology. Prior to Novartis, Mari was a partner at McKinsey & Company in New York and in Switzerland in pharmaceuticals and medical products.

Mari holds a doctorate in neuroscience from Harvard Medical School.

IPN price

€105.70

 €0.90 (0.86%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2025

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue